AstraZeneca, Bristol-Myers Squibb jointly launch diabetes drug
Livemint - 36 minutes ago
Mumbai: AstraZeneca Pharma India Ltd and the Indian arm of Bristol-Myers Squibb alliance has launched a type-II diabetes drug Saxagliptin in India, both the firms said in a joint statement on ...
http://digg.com/u1SHC6
No comments:
Post a Comment